These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 31124293)

  • 1. An estrogen receptor (ER)-related signature in predicting prognosis of ER-positive breast cancer following endocrine treatment.
    Tang J; Cui Q; Zhang D; Liao X; Zhu J; Wu G
    J Cell Mol Med; 2019 Aug; 23(8):4980-4990. PubMed ID: 31124293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prognostic eight-lncRNA expression signature in predicting recurrence of ER-positive breast cancer receiving endocrine therapy.
    Tang J; Cui Q; Zhang D; Kong D; Liao X; Ren J; Gong Y; Wu G
    J Cell Physiol; 2020 May; 235(5):4746-4755. PubMed ID: 31663114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Potential Prognostic Long Noncoding RNA Signature to Predict Recurrence among ER-positive Breast Cancer Patients Treated with Tamoxifen.
    Wang K; Li J; Xiong YF; Zeng Z; Zhang X; Li HY
    Sci Rep; 2018 Feb; 8(1):3179. PubMed ID: 29453409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a prognostic LncRNA signature for ER-positive, ER-negative and triple-negative breast cancers.
    Liu D
    Breast Cancer Res Treat; 2020 Aug; 183(1):95-105. PubMed ID: 32601968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prognostic 10-lncRNA expression signature for predicting the risk of tumour recurrence in breast cancer patients.
    Tang J; Ren J; Cui Q; Zhang D; Kong D; Liao X; Lu M; Gong Y; Wu G
    J Cell Mol Med; 2019 Oct; 23(10):6775-6784. PubMed ID: 31429520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel 18-gene signature for predicting relapse in ER-positive, HER2-negative breast cancer.
    Buus R; Yeo B; Brentnall AR; Klintman M; Cheang MCU; Khabra K; Sestak I; Gao Q; Cuzick J; Dowsett M
    Breast Cancer Res; 2018 Sep; 20(1):103. PubMed ID: 30180877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EarlyR: A Robust Gene Expression Signature for Predicting Outcomes of Estrogen Receptor-Positive Breast Cancer.
    Buechler SA; Gökmen-Polar Y; Badve SS
    Clin Breast Cancer; 2019 Feb; 19(1):17-26.e8. PubMed ID: 30097312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An immune-related prognostic signature for predicting breast cancer recurrence.
    Tian Z; Tang J; Liao X; Yang Q; Wu Y; Wu G
    Cancer Med; 2020 Oct; 9(20):7672-7685. PubMed ID: 32841536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and validation of single-sample breast cancer radiosensitivity gene expression predictors.
    Sjöström M; Staaf J; Edén P; Wärnberg F; Bergh J; Malmström P; Fernö M; Niméus E; Fredriksson I
    Breast Cancer Res; 2018 Jul; 20(1):64. PubMed ID: 29973242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Network-based approach to identify prognosis-related genes in tamoxifen-treated patients with estrogen receptor-positive breast cancer.
    Wang Y; Gong X; Zhang Y
    Biosci Rep; 2021 Sep; 41(9):. PubMed ID: 34406386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of a 92-probe signature in breast cancer.
    Akter S; Choi TG; Nguyen MN; Matondo A; Kim JH; Jo YH; Jo A; Shahid M; Jun DY; Yoo JY; Nguyen NN; Seo SW; Ali L; Lee JS; Yoon KS; Choe W; Kang I; Ha J; Kim J; Kim SS
    Oncotarget; 2015 Jun; 6(17):15662-80. PubMed ID: 25883221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcomes linked to expression of gene subsets for protein hormones and their cognate receptors from LCM-procured breast carcinoma cells.
    Daniels MW; Brock GN; Wittliff JL
    Breast Cancer Res Treat; 2017 Jan; 161(2):245-258. PubMed ID: 27858316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tamoxifen therapy benefit predictive signature coupled with prognostic signature of post-operative recurrent risk for early stage ER+ breast cancer.
    Cai H; Li X; Li J; Ao L; Yan H; Tong M; Guan Q; Li M; Guo Z
    Oncotarget; 2015 Dec; 6(42):44593-608. PubMed ID: 26527319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative Prognostic and Predictive Value of Gene Signature and Histologic Grade in Estrogen Receptor-Positive, HER2-Negative Breast Cancer.
    Iwamoto T; Kelly C; Mizoo T; Nogami T; Motoki T; Shien T; Taira N; Hayashi N; Niikura N; Fujiwara T; Doihara H; Matsuoka J
    Clin Breast Cancer; 2016 Apr; 16(2):95-100.e1. PubMed ID: 26631838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptomic signature predicts the distant relapse in patients with ER+ breast cancer treated with tamoxifen for five years.
    Zhou H; Lv Q; Guo Z
    Mol Med Rep; 2018 Feb; 17(2):3152-3157. PubMed ID: 29257261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholesterol biosynthesis pathway as a novel mechanism of resistance to estrogen deprivation in estrogen receptor-positive breast cancer.
    Simigdala N; Gao Q; Pancholi S; Roberg-Larsen H; Zvelebil M; Ribas R; Folkerd E; Thompson A; Bhamra A; Dowsett M; Martin LA
    Breast Cancer Res; 2016 Jun; 18(1):58. PubMed ID: 27246191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of key genes relevant to the prognosis of ER-positive and ER-negative breast cancer based on a prognostic prediction system.
    Xiao B; Hang J; Lei T; He Y; Kuang Z; Wang L; Chen L; He J; Zhang W; Liao Y; Sun Z; Li L
    Mol Biol Rep; 2019 Apr; 46(2):2111-2119. PubMed ID: 30888555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Copy number profiling of Oncotype DX genes reveals association with survival of breast cancer patients.
    Ahmed W; Malik MFA; Saeed M; Haq F
    Mol Biol Rep; 2018 Dec; 45(6):2185-2192. PubMed ID: 30225582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct p53 gene signatures are needed to predict prognosis and response to chemotherapy in ER-positive and ER-negative breast cancers.
    Coutant C; Rouzier R; Qi Y; Lehmann-Che J; Bianchini G; Iwamoto T; Hortobagyi GN; Symmans WF; Uzan S; Andre F; de Thé H; Pusztai L
    Clin Cancer Res; 2011 Apr; 17(8):2591-601. PubMed ID: 21248301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A glycolysis-related gene expression signature in predicting recurrence of breast cancer.
    Tang J; Luo Y; Wu G
    Aging (Albany NY); 2020 Nov; 12(24):24983-24994. PubMed ID: 33201835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.